The widely covered impending ouster of FDA Commissioner Marty Makary not long after the exit of controversial biologics head ...
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to ...
(Image source: https://gisaid.org/rsv-subtypes-dashboard) ...
New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...
Acting Center for Drug Evaluation and Research Director Tracy Beth Høeg reportedly disagreed with staff who wanted to approve ...
The FDA turned away Ebvallo in January, taking issue with the design of the registrational trial. In a recent meeting, however, the agency agreed that the study could in fact support the cell ...
Despite the continued decline of Pfizer's COVID-19 products, shares stayed stable on Tuesday morning after the New York ...
The selloff in Eli Lilly's shares was “overdone,” according to RBC Capital Markets, which noted that the overall safety ...
Pfizer-backed cancer company CellCentric will use the cash to support the launch of a pivotal myeloma trial testing its ...
Analysts and investors alike had been eagerly awaiting sales figures for Novo Nordisk’s Wegovy pill. The answer blew past ...
Sarepta Therapeutics has put in place several initiatives to help its gene therapy Elevidys return to growth, but recovery ...
The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results